Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease
Authors:
- Jin Wan KimJKJin Wan Kim
- Tariq J. DayahTDTariq J. Dayah
- Awad JavaidAwad Javaid
- Dominique J. MonlezunDMDominique J. Monlezun
- Dinu V. BalanescuDBDinu V. Balanescu
- Teodora DonisanTDTeodora Donisan
- Kaveh KarimzadKKKaveh Karimzad
- Abdul HakeemAHAbdul Hakeem
- David L. BooneDBDavid L. Boone
- Nicolas PalaskasNPNicolas Palaskas
- Juan Lopez-MatteiJLJuan Lopez-Mattei
- Peter Y. KimPKPeter Y. Kim
Open Access
Abstract
Background and Objectives: Cancer and coronary artery disease (CAD) often coexist. Compared to quantitative coronary angiography (QCA), fractional flow reserve (FFR) has emerged as a more reliable method of identifying significant coronary stenoses. We aimed to assess the specific management, safety and outcomes of FFR-guided percutaneous coronary intervention (PCI) in cancer patients with stable CAD. Materials and Methods: FFR was used to assess cancer patients that underwent coronary angiography for stable CAD between September 2008 and May 2016, and were found to have ≥50% stenosis by QCA. Patients with lesions with an FFR > 0.75 received medical therapy alone, while those with FFR ≤ 0.75 were revascularized. Procedure-related complications, all-cause mortality, nonfatal myocardial infarction, or urgent revascularizations were analyzed. Results: Fifty-seven patients with stable CAD underwent FFR on 57 lesions. Out of 31 patients with ≥70% stenosis as measured by QCA, 14 (45.1%) had an FFR ≥ 0.75 and lesions were reclassified as moderate and did not receive PCI nor DAPT. Out of 26 patients with p = 0.03). Conclusions: Further studies are needed to define the optimal therapeutic approach for cancer patients with CAD. Using an FFR cut-off point of 0.75 to guide PCI translates into fewer interventions and can facilitate cancer care. There was an overall reduction in mortality in patients that received a stent, suggesting increased resilience to cancer therapy and progression.Keywords
This publication has 16 references indexed in Scilit:
- SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista)Catheterization and Cardiovascular Interventions, 2016
- Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trialThe Lancet, 2015
- Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with CancerSeminars in Thrombosis and Hemostasis, 2015
- Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trialEuropean Heart Journal, 2015
- Prognostic Value of Fractional Flow ReserveJACC, 2014
- Fractional Flow Reserve–Guided PCI for Stable Coronary Artery DiseaseNew England Journal of Medicine, 2014
- Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trialEuropean Heart Journal, 2014
- Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary DiseaseNew England Journal of Medicine, 2012
- Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Treatment in Patients With Angiographically Equivocal Left Main Coronary Artery StenosisCirculation, 2009
- Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery StenosesNew England Journal of Medicine, 1996